ghk-cu protocol for skin health and aesthetics GHK Peptide Injection GHK Cu GHK-Cu Copper Peptide: Dosage, Before

Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P

Available Dosages

However, unlike finasteride, copper peptides are non-hormonal and do not cause side effects like decreased libido

A trial of T4 may be warranted in a few patients eg if they are symptomatic with goitre or planning pregnancy (see below)